ReviewOcular oncology and pathology2017

Systemic BRAF/MEK Inhibitors as a Potential Treatment Option in Metastatic Conjunctival Melanoma.

Joel M Mor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.